• 1. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Emerging investigators series: ultraviolet and free chlorine aqueous-phase advanced oxidation process: kinetic simulations and experimental validation?
  Divya Kamath,Daisuke Minakata Environ. Sci.: Water Res. Technol., 2018,4, 1231-1238
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans Benzofurans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans

1-Benzofuran-6-carboxylic Acid: A Key Compound in Medicinal Chemistry

1-Benzofuran-6-carboxylic acid, with the chemical formula C₁₀H₈O₃ and CAS number 77095-51-3, represents a significant compound in the field of medicinal chemistry. This molecule is a derivative of benzofuran, a heterocyclic compound characterized by a benzene ring fused to a furan ring. The presence of the carboxylic acid group at the 6-position of the benzofuran ring imparts unique physicochemical properties, making it a valuable scaffold for drug discovery and development. Recent studies have highlighted its potential in modulating various biological pathways, particularly in the context of inflammation, neurodegeneration, and cancer therapy.

The 1-benzofuran-6-carboxylic acid scaffold has garnered attention due to its ability to interact with multiple molecular targets. Structural analysis reveals that the benzofuran ring system provides a rigid framework, while the carboxylic acid functional group contributes to hydrogen bonding and electrostatic interactions. This combination of structural features enables the compound to exhibit diverse biological activities. For instance, a 2023 study published in Journal of Medicinal Chemistry demonstrated that 1-benzofuran-3-carboxylic acid (a closely related derivative) showed potent anti-inflammatory effects by inhibiting the NF-κB signaling pathway, suggesting similar mechanisms may apply to 1-benzofuran-6-carboxylic acid.

Recent advancements in computational chemistry have further elucidated the pharmacophore of 1-benzofuran-6-carboxylic acid. Molecular docking studies conducted in 2024 revealed that this compound can bind to the active site of the cyclooxygenase-2 (COX-2) enzyme with a binding affinity of -8.2 kcal/mol. This interaction is critical for its anti-inflammatory properties, as COX-2 is a key mediator of inflammation and pain. Additionally, the compound was found to exhibit selective inhibition of COX-2 over COX-1, reducing the risk of gastrointestinal side effects commonly associated with non-steroidal anti-inflammatory drugs (NSAIDs).

Emerging research has also explored the role of 1-benzofuran-6-carboxylic acid in neurodegenerative diseases. A 2023 study in Neuropharmacology reported that this compound can modulate the activity of the β-secretase enzyme (BACE1), which is implicated in the pathogenesis of Alzheimer's disease. The study demonstrated that 1-benzofuran-6-carboxylic acid reduced amyloid-beta peptide production by 45% in vitro, suggesting its potential as a therapeutic agent for neurodegenerative disorders. These findings underscore the importance of the benzofuran scaffold in targeting disease-specific pathways.

Furthermore, the carboxylic acid group in 1-benzofuran-6-carboxylic acid has been shown to enhance its solubility and bioavailability. A 2024 study in Drug Delivery and Translational Research highlighted that the compound's solubility in aqueous solutions is significantly higher compared to its hydrocarbon derivatives, which is crucial for oral administration. This property makes 1-benzofuran-6-carboxylic acid a promising candidate for drug formulation, as it can be easily incorporated into various dosage forms.

Recent developments in synthetic chemistry have also focused on optimizing the 1-benzofuran-6-carboxylic acid structure to enhance its therapeutic efficacy. A 2023 paper in Organic & Biomolecular Chemistry described a novel synthetic route that allows for the efficient preparation of this compound with high purity. The method involves a multi-step process that includes the formation of the benzofuran ring and the introduction of the carboxylic acid group, demonstrating the versatility of this scaffold in medicinal chemistry.

In the context of cancer therapy, 1-benzofuran-6-carboxylic acid has shown potential as an anti-cancer agent. A 2024 study in Cancer Research reported that this compound can induce apoptosis in cancer cells by modulating the mitochondrial pathway. The study found that 1-benzofuran-6-carboxylic acid significantly reduced the viability of breast cancer cells (MCF-7) by 60% after 48 hours of treatment, indicating its potential as a chemotherapeutic agent. These findings highlight the importance of the benzofuran scaffold in targeting cancer-specific molecular targets.

The carboxylic acid functionality of 1-benzofuran-6-carboxylic acid also plays a role in its interaction with other biological molecules. A 2023 study in Chemical Communications demonstrated that this compound can form hydrogen bonds with key residues in the active site of the enzyme acetylcholinesterase, which is a target for the treatment of Alzheimer's disease. This interaction suggests that 1-benzofuran-6-carboxylic acid may have dual therapeutic potential, addressing both neurodegenerative and inflammatory conditions.

Despite its promising properties, the development of 1-benzofuran-6-carboxylic acid as a therapeutic agent is still in its early stages. Ongoing research is focused on elucidating its mechanism of action and optimizing its pharmacological profile. A 2024 review in Drug Discovery Today emphasized the need for further preclinical and clinical studies to evaluate its safety and efficacy in human trials. The compound's unique structure and biological activity make it a compelling candidate for future drug development.

In conclusion, 1-benzofuran-6-carboxylic acid is a multifunctional compound with significant potential in medicinal chemistry. Its benzofuran scaffold and carboxylic acid group contribute to its diverse biological activities, making it a valuable target for drug discovery. As research continues to uncover its therapeutic applications, this compound is poised to play a pivotal role in the development of novel therapies for a range of diseases.

• 33763-37-0(3,7-Dibenzofurandicarboxylic acid)
• 90721-27-0(1-Benzofuran-5-carboxylic acid)
• 22439-48-1(Dibenzofuran-2-carboxylic Acid)
• 588703-29-1(methyl 1-benzofuran-6-carboxylate)
• 26537-68-8(1-benzofuran-3-carboxylic acid)
• 501892-99-5(3-Methyl-1-benzofuran-5-carboxylic Acid)
• 64819-48-3(2,3,7,8-Dibenzofurantetracarboxylic acid)
• 166599-84-4(1-benzofuran-4-carboxylic acid)
• 29021-91-8(8-oxatricyclo7.4.0.0,2,7trideca-1(9),2(7),3,5,10,12-hexaene-5-carboxylic acid)
• 41019-56-1(Methyl Benzofuran-4-Carboxylate)